MTOR and diabetic kidney disease: In 2019, Li et al. reported in a diabetic nephropathy model that phosphatase and tensin homolog (PTEN), which is a negative regulator of protein kinase B and mechanistic target of rapamycin (mTOR), promotes IL-6 [23].